2022 eContouring Central Nervous System Cancer - Library Cases

This educational activity will provide case-based education on neuroanatomic contouring for the two most common brain tumors seen in radiation oncology practice: brain metastases and glioma. Attendees will be asked to contour tumor targets for intact brain metastases, a resected brain metastasis, and a resected glioblastoma.  They will also be asked to contour radiosensitive normal tissue structures, including the hippocampal dentate gyrus, the optic chiasm/nerves, the brainstem, the cochlea, and the lenses. Through this practice and didactic feedback, attendees will learn principles of neuroanatomic contouring that better equips them to radiotherapeutically manage primary and metastatic brain tumor patients.

 

Target Audience

This program is designed to meet the interest of radiation oncologists, physicists, radiation dosimetrists and radiation oncology residents.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Neuroanatomically contour the hippocampal dentate gyrus and other normal tissues in the brain.
  • Neuroanatomically contour an intact brain metastasis, a resected brain metastasis, and a glioblastoma.
  • Apply neuroanatomic principles to the radiotherapy planning of primary and metastatic brain tumor patients.

 

Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.
Course opens: 
11/07/2022
Course expires: 
11/06/2024
Cost:
$149.00
Rating: 
0

Vinai Gondi, MD is employed by Northwestern Medicine Center Warrenville and Proton Center. He is a partner in Radiation Oncology Consultants, LTD. and receives compensation from Novocure, UpToDate, and ImmunoChem Therapeutics.

The person(s) above served as the developer(s) of this activity. Additionally, the Education  Committees had control over the content of this activity.

Disclosure link: 
Education Committee

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.25 Certificate of Attendance
    This activity was designated for 1.25 AMA PRA Category 1 Credit™.

Price

Cost:
$149.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

  • Nonmember: $149.00
  • Member: $99.00
  • This webinar is free to members-in-training.

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.